DOI QR코드

DOI QR Code

Association of Intracellular $T_H1-T_H2$ Balance in CD4+ T-cells and MIP-$1{\alpha}$ in CD8+ T-cells with Disease Severity in Adults with Dengue

  • Kadhiravan, Tamilarasu (Department of Medicine, All India Institute of Medical Sciences) ;
  • Saxena, Ankit (Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences) ;
  • Singh, Amar (Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences) ;
  • Broor, Shobha (Department of Microbiology, All India Institute of Medical Sciences) ;
  • Sharma, Surendra K. (Department of Medicine, All India Institute of Medical Sciences) ;
  • Mitra, Dipendra K. (Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences)
  • Received : 2010.09.04
  • Accepted : 2010.09.20
  • Published : 2010.10.30

Abstract

Background: We tested the hypothesis that dengue haemorrhagic fever (DHF) is associated with a $T_H1$-skewed immune response as opposed to dengue fever (DF). Methods: We estimated intracellular (in T-cells) and serum levels of designate $T_H1/T_H2$ cytokines [interferon-${\gamma}$ (IFN-${\gamma}$), interleukin-4 (IL-4), and tumor necrosis factor-${\alpha}$] and macrophage inflammatory protein-$1{\alpha}$ (MIP-$1{\alpha}$) at admission, 48h, and day 5 in 20 adults with dengue (DF=10, DHF=10) and 10 dengue-naive healthy controls. Results: At admission, intracellular IFN-${\gamma}$/IL-4 ratio in CD4+ T-cells and proportion of MIP-$1{\alpha}$-positive CD8+ T-cells were significantly higher in patients with DHF [7.21 (5.36~10.81) vs. 3.04 (1.75~4.02); p=0.011 and 6.2% (3.2~8.2%) vs. 2.4% (2.0~3.6%); p=0.023]. The latter showed a significant positive correlation with IFN-${\gamma}$/IL-4 ratio in CD4+ T-cells (Spearman's rho=0.64; p=0.003), percentage-change in haematocrit (rho=0.47; p=0.048), and serum alanine amino-transferase level (rho=0.61; p=0.009). Conclusion: We conclude that DHF is associated with a $T_H1$-skewed immune response. Further, MIP-$1{\alpha}$ in CD8+ T-cells is an important immunologic correlate of disease severity in dengue.

Keywords

References

  1. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV: Dengue and dengue haemorrhagic fever. Lancet 352;971-977, 1998 https://doi.org/10.1016/S0140-6736(97)12483-7
  2. Burke DS, Nisalak A, Johnson DE, Scott RM: A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38;172-180, 1988 https://doi.org/10.4269/ajtmh.1988.38.172
  3. Green S, Rothman A: Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 19;429-436, 2006 https://doi.org/10.1097/01.qco.0000244047.31135.fa
  4. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL: Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185;1213-1221, 2002 https://doi.org/10.1086/340365
  5. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA: Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179;755-762, 1999 https://doi.org/10.1086/314680
  6. Spain-Santana TA, Marglin S, Ennis FA, Rothman AL: MIP-1 alpha and MIP-1 beta induction by dengue virus. J Med Virol 65;324-330, 2001 https://doi.org/10.1002/jmv.2037
  7. Mabalirajan U, Kadhiravan T, Sharma SK, Banga A, Ghosh B: Th(2) immune response in patients with dengue during defervescence: preliminary evidence. Am J Trop Med Hyg 72;783-785, 2005
  8. National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Dengue/dengue haemorrhagic fever - Dengue cases and deaths since 2001. Available at URL: http://www.nvbdcp.gov.in/dengueC&D. html. Accessed 17 June, 2009
  9. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ: The WHO dengue classification and case definitions: time for a reassessment. Lancet 368;170-173, 2006 https://doi.org/10.1016/S0140-6736(06)69006-5
  10. World Health Organization (WHO). Dengue hemorrhagic fever: diagnosis, treatment, prevention and control, 2nd Edn. Geneva: WHO; p12-23, 1997
  11. Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, Kabra SK, Broor S: Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol J 5;1, 2008 https://doi.org/10.1186/1743-422X-5-1
  12. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF: Liver biochemical tests and dengue fever. Am J Trop Med Hyg 47;265-270, 1992
  13. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269;1583- 1585, 1995 https://doi.org/10.1126/science.7667639
  14. Murgue B, Cassar O, Deparis X, Guigon M, Chungue E: Implication of macrophage inflammatory protein-1alpha in the inhibition of human haematopoietic progenitor growth by dengue virus. J Gen Virol 79;1889-1893, 1998 https://doi.org/10.1099/0022-1317-79-8-1889
  15. Halstead SB: Pathogenesis of dengue: challenges to molecular biology. Science 239;476-481, 1988 https://doi.org/10.1126/science.3277268
  16. Kontny U, Kurane I, Ennis FA: Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 62;3928-3933, 1988
  17. Schroder K, Hertzog PJ, Ravasi T, Hume DA: Interferongamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75;163-189, 2004
  18. Bukowski JF, Kurane I, Lai CJ, Bray M, Falgout B, Ennis FA: Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol 63;5086-5091, 1989
  19. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV: Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 184;1369-1373, 2001 https://doi.org/10.1086/324320
  20. Cook DN, Smithies O, Strieter RM, Frelinger JA, Serody JS: CD8+ T cells are a biologically relevant source of macrophage inflammatory protein-1 alpha in vivo. J Immunol 162;5423-5428, 1999
  21. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA: Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158;4129-4136, 1997
  22. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS: Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28;183-188, 2000 https://doi.org/10.1111/j.1574-695X.2000.tb01474.x
  23. Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, Yu HR, Cheng JT, Yang KD: Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 44;43-50, 2005 https://doi.org/10.1016/j.femsim.2004.11.012
  24. Chaturvedi UC, Raghupathy R, Pacsa AS, Elbishbishi EA, Agarwal R, Nagar R, Misra A, Kapoor S, Mathur A, Khan MAY, Azizieh F. Shift from a Th1-type response to Th2-type in dengue haemorrhagic fever. Curr Sci 76;63-69, 1999
  25. Chareonsook O, Foy HM, Teeraratkul A, Silarug N: Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect 122;161-166, 1999 https://doi.org/10.1017/S0950268898001617
  26. Nguyen TH, Nguyen TL, Lei HY, Lin YS, Le BL, Huang KJ, Lin CF, Do QH, Vu TQ, Lam TM, Yeh TM, Huang JH, Liu CC, Halstead SB: Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg 72;370-374, 2005
  27. Rodriguez L, Gonzalez C, Flores L, Jimenez-Zamudio L, Graniel J, Ortiz R: Assessment by flow cytometry of cytokine production in malnourished children. Clin Diagn Lab Immunol 12;502-507, 2005
  28. Luhn K, Simmons CP, Moran E, Dung NT, Chau TN, Quyen NT, Thao le TT, Van Ngoc T, Dung NM, Wills B, Farrar J, McMichael AJ, Dong T, Rowland-Jones S: Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med 204;979-985, 2007 https://doi.org/10.1084/jem.20061381

Cited by

  1. Frequency of T Cell Expressing Th1 and Th2 Associated Chemokine Receptor in Patients With Renal Allograft Dysfunction vol.44, pp.1, 2010, https://doi.org/10.1016/j.transproceed.2011.12.047
  2. Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA vol.106, pp.3, 2010, https://doi.org/10.1016/j.trstmh.2011.10.009
  3. Polymorphism of DC-SIGN (CD209) Promoter in Association with Clinical Symptoms of Dengue Fever vol.27, pp.5, 2010, https://doi.org/10.1089/vim.2013.0119
  4. CLINICAL FEATURES AND SIGNIFICANCE OF CYTOKINE IL-4 IN CHILDREN WITH DENGUE AT A TERTIARY CARE CENTRE vol.3, pp.99, 2010, https://doi.org/10.18410/jebmh/2016/1127